Cited by 57Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementCardiovascular Function and Risk Factors

Type 2 diabetes and cardiovascular disease: what next?

Open access
Joseph, Joshua J., Golden, Sherita Hill·2014·Current Opinion in Endocrinology, Diabetes & Obesity

Abstract

PURPOSE OF REVIEW: Cardiovascular disease (CVD) is the leading cause of mortality in type 2 diabetes mellitus (T2DM), and modifying cardiovascular risk through lifestyle intervention and pharmacologic therapy is paramount. This review focuses on recent advances in treatment of classical (traditional) cardiovascular risk factors and highlights the impact of novel risk factors, including sleep disorders, socioeconomic status and chronic psychological stress on CVD in T2DM. RECENT FINDINGS: Obesity is a substantial cardiovascular risk factor, and recently, large trials of lifestyle and surgical (e.g. gastric bypass) interventions impact on CVD in overweight and obese patients have been reported. Lifestyle intervention including low calorie diet and exercise reduced individual cardiovascular risk factors but did not decrease the rate of long-term cardiovascular events. Bariatric surgery was beneficial in reducing cardiovascular risk factors and long-term cardiovascular events. Sleep insufficiency, poor sleep quality and obstructive sleep apnoea lead to higher CVD and further research is needed to characterize the benefit of treating sleep disorders on long-term cardiovascular events in T2DM. Lastly, socioeconomic status and chronic psychological stress independently have a major impact on increasing CVD in T2DM, and public health policies to reduce this burden will be important to address over the coming decade. SUMMARY: CVD in T2DM is multifactorial and requires a multifaceted approach in reducing known cardiovascular risks at the individual patient level through lifestyle, pharmacotherapy and surgical interventions and at the societal level through public health policies that support reduction in classical and novel cardiovascular risk factors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/med.0000000000000044

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Research works printed but not linked: 3

  1. [48]The Look AHEAD Research Group Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes N Engl J Med 2013 369 145 154 23796131 PMC3791615
  2. [60]Colwell JA Cushman M Inzucchi SE ADA/AHA/ACCF scientific statement Circulation 2010 121 2694 2701 20508178
  3. [68]Colten HR Altevogt BM Institute of Medicine (U.S.), Committee on Sleep Medicine and Research Sleep disorders and sleep deprivation: an unmet public health problem [Internet] Washington, DC National Academies Press 2006 http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=nap11617 Accessed 11 October 2013 20669438

Cited by

Sorted by citations

Authors
Joseph, J. J., & Golden, S. H.
Affiliations
Johns Hopkins University (US)
Corresponding author
Golden, Sherita Hill
Venue
Current Opinion in Endocrinology, Diabetes & Obesity
Published
2014-04
Volume
21
Issue
2
Pages
109-120
ISSN
1752-296X (ISSN-L)
OpenAlex
W2110845218
Cited by
57
References
127
Citations by year
2026: 3 · 2024: 7 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 6 · 2019: 3 · 2018: 6 · 2017: 7 · 2016: 6 · 2015: 8 · 2014: 2 · 2013: 1
FWCI
1.22
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Endocrinology Diabetes and Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079637, T32DK062707)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
type 2 diabetes, cardiovascular disease, cardiovascular risk factors, obesity, bariatric surgery, lifestyle intervention, hypocaloric diet, physical activity, sleep disorders, obstructive sleep apnea, socioeconomic status, chronic psychological stress, public health policy
MeSH terms
Anticholesteremic Agents, Aspirin, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Drug Therapy, Combination, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Obesity, Risk Factors, Sleep Wake Disorders, Socioeconomic Factors, Stress, Psychological, Exercise, Simvastatin, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review